The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Himadri Speciality Chemical Ltd PAT Grows by 48% to Rs. 183 Cr in Q1FY26
Quarterly Highlights of Standalone Financials: Particular (in Cr) Q1FY26 Q1FY25 Y-o-Y Sales Volume (MT) 140,090 139,175 1% EBITDA 233.97 187.65 24.68%…
ASSOCHAM India Mines & Minerals Conclave 2026 Policy Reforms and Sustainable Mining Key to India’s Mineral Security: Arun Kumar
Bhubaneswar, Mar 13th: The Associated Chambers of Commerce and Industry of India (ASSOCHAM) convened the India Mines & Minerals Conclave…
Successful Culmination of National Workshop on Earth Sciences at IIT Roorkee
Roorkee,30th December 2023 The National Workshop on Earth Sciences held at the Indian Institute of Technology Roorkee (IITR) concluded on…